JESSALYNN THURMAN: Open Payments
NPI 1821754631 · FLORENCE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 11 payments from 8 companies in 2025. Trend: 2023 $625 · 2024 $515 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $124 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| ViiV Healthcare Company | 2 | $35 |
| Baxter Healthcare | 2 | $34 |
| Paratek Pharmaceuticals, Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| La Jolla Pharmaceutical Company | 1 | $22 |
| Invivyd Inc | 1 | $17 |
Products named: KISUNLA, DOVATO, NUZYRA, PIFELTRO, ZEVTERA, Hillrom - Volara System, PEMGARDA, DELSTRIGO.
Industry payments across MS — which companies pay providers there.
